Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281749691> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4281749691 endingPage "e001974" @default.
- W4281749691 startingPage "e001974" @default.
- W4281749691 abstract "We aim to assess the association of cardiovascular medications with outcomes of patients referred to the diagnostic heart failure (HF) clinic with symptoms or signs of possible HF, raised N-terminal pro-brain-type natriuretic peptide (NT-proBNP) but no evidence of HF on transthoracic echocardiography (TTE).Data were collected prospectively into the Sheffield HEArt Failure (SHEAF) registry between April 2012 and January 2020. The inclusion criteria were symptoms or signs suggestive of HF, NT-proBNP >400 pg/mL, but no evidence of HF on TTE. Cox proportional-hazards regression model was used to investigate the association between the survival time of patients and different cardiovascular medications. The outcome was defined as all-cause mortality.From the SHEAF registry, we identified 1766 patients with raised NT-proBNP with no evidence of HF on TTE. Survival was higher among the younger patients, and among those with hypertension or atrial fibrillation (AF). Mortality was increased with male gender, valvular heart disease and chronic kidney disease. Using univariate Cox proportional-hazards regression, the only cardiac therapeutic agent independently associated with all-cause mortality was beta-blocker (HR 0.86; 95% CI: 0.77 to 0.97; p=0.02). The use of beta-blockers was significantly higher in patients with AF (63% vs 39%, p<0.01) and hypertension (51% vs 42%, p<0.01). However, using multivariate Cox proportional-hazards regression to adjust for all variables associated with mortality, the influence of beta-blockers became non-significant (HR 0.96; 95% CI: 0.85 to 1.1, p=0.49).When all variables associated with mortality are considered, none of the cardiovascular agents are associated with the improved survival of patients with suspected HF, raised NT-proBNP but no HF on echocardiography." @default.
- W4281749691 created "2022-06-13" @default.
- W4281749691 creator A5000668741 @default.
- W4281749691 creator A5004045527 @default.
- W4281749691 creator A5031891009 @default.
- W4281749691 creator A5040950222 @default.
- W4281749691 creator A5050571372 @default.
- W4281749691 creator A5056770413 @default.
- W4281749691 creator A5058792284 @default.
- W4281749691 creator A5070777619 @default.
- W4281749691 date "2022-06-01" @default.
- W4281749691 modified "2023-09-30" @default.
- W4281749691 title "Cardiovascular medication in patients with raised NT-proBNP, but no heart failure in the SHEAF registry" @default.
- W4281749691 cites W2060223808 @default.
- W4281749691 cites W2063984997 @default.
- W4281749691 cites W2074671977 @default.
- W4281749691 cites W2098538911 @default.
- W4281749691 cites W2137147239 @default.
- W4281749691 cites W2205428684 @default.
- W4281749691 cites W2213907223 @default.
- W4281749691 cites W2546997268 @default.
- W4281749691 cites W2991321864 @default.
- W4281749691 cites W3032635050 @default.
- W4281749691 cites W3039237107 @default.
- W4281749691 cites W3119512526 @default.
- W4281749691 doi "https://doi.org/10.1136/openhrt-2022-001974" @default.
- W4281749691 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35649572" @default.
- W4281749691 hasPublicationYear "2022" @default.
- W4281749691 type Work @default.
- W4281749691 citedByCount "0" @default.
- W4281749691 crossrefType "journal-article" @default.
- W4281749691 hasAuthorship W4281749691A5000668741 @default.
- W4281749691 hasAuthorship W4281749691A5004045527 @default.
- W4281749691 hasAuthorship W4281749691A5031891009 @default.
- W4281749691 hasAuthorship W4281749691A5040950222 @default.
- W4281749691 hasAuthorship W4281749691A5050571372 @default.
- W4281749691 hasAuthorship W4281749691A5056770413 @default.
- W4281749691 hasAuthorship W4281749691A5058792284 @default.
- W4281749691 hasAuthorship W4281749691A5070777619 @default.
- W4281749691 hasBestOaLocation W42817496911 @default.
- W4281749691 hasConcept C126322002 @default.
- W4281749691 hasConcept C164705383 @default.
- W4281749691 hasConcept C2778198053 @default.
- W4281749691 hasConcept C2779161974 @default.
- W4281749691 hasConcept C50382708 @default.
- W4281749691 hasConcept C71924100 @default.
- W4281749691 hasConceptScore W4281749691C126322002 @default.
- W4281749691 hasConceptScore W4281749691C164705383 @default.
- W4281749691 hasConceptScore W4281749691C2778198053 @default.
- W4281749691 hasConceptScore W4281749691C2779161974 @default.
- W4281749691 hasConceptScore W4281749691C50382708 @default.
- W4281749691 hasConceptScore W4281749691C71924100 @default.
- W4281749691 hasFunder F4320311904 @default.
- W4281749691 hasIssue "1" @default.
- W4281749691 hasLocation W42817496911 @default.
- W4281749691 hasLocation W42817496912 @default.
- W4281749691 hasLocation W42817496913 @default.
- W4281749691 hasLocation W42817496914 @default.
- W4281749691 hasLocation W42817496915 @default.
- W4281749691 hasOpenAccess W4281749691 @default.
- W4281749691 hasPrimaryLocation W42817496911 @default.
- W4281749691 hasRelatedWork W1967841144 @default.
- W4281749691 hasRelatedWork W2018480046 @default.
- W4281749691 hasRelatedWork W2064495796 @default.
- W4281749691 hasRelatedWork W2067977631 @default.
- W4281749691 hasRelatedWork W2300086221 @default.
- W4281749691 hasRelatedWork W2319489406 @default.
- W4281749691 hasRelatedWork W2333279585 @default.
- W4281749691 hasRelatedWork W2603808924 @default.
- W4281749691 hasRelatedWork W2763816051 @default.
- W4281749691 hasRelatedWork W3029306217 @default.
- W4281749691 hasVolume "9" @default.
- W4281749691 isParatext "false" @default.
- W4281749691 isRetracted "false" @default.
- W4281749691 workType "article" @default.